PERSICA PHARMACEUTICALS LIMITED
Developing a transformative, non-opioid treatment for patients suffering from chronic Low Back Pain with Modic changes
Developing a transformative, non-opioid treatment for patients suffering from chronic Low Back Pain with Modic changes
PERSICA PHARMACEUTICALS LIMITED is a clinical stage pharma company based in the United Kingdom. The company is developing a novel treatment for patients suffering from chronic low back pain due to infection. Persica has completed recruitment for its Phase 1b study to investigate the efficacy of PP353 compared to placebo in the treatment of chronic low back pain associated with bone oedema. The study details can be found at clinicaltrials.gov/ct2/show/NCT04238676. Specializing in the Health Care and Pharmaceutical industries, Persica Pharmaceuticals was founded in 2013. No specific information is available about the last investment and investors.
There is no investment information
No recent news or press coverage available for PERSICA PHARMACEUTICALS LIMITED.
We care about your data, and we'd love to use cookies make your experience better.
